Active Biotech's election committee appointed
(Thomson Reuters ONE) -
In accordance with a decision made by the Annual General Meeting held on May
6, 2010, the Election Committee shall comprise the representatives for the three
largest shareholders, as per end of September, and the Chairman of the Board.
For the 2011 Annual General Meeting, the Election Committee shall propose Board
members and a Chairman of the Board, and fees to Board members and auditors. The
following individuals were appointed representatives for the largest
shareholders and, accordingly, are members of the Election Committee:
Johnny Sommarlund, MGA Holding
Tomas Billing, Nordstjernan
Peter Thelin, Brummer & Partners
Under the leadership of the Chairman of the Board, Mats Arnhög, the Election
Committee shall prepare proposals for the Board of Directors that are to be
presented to and decided upon at the Annual General Meeting on May 5, 2011.
Lund, November 3, 2010
Active Biotech AB (publ)
Tomas Leanderson
President and CEO
About Active Biotech
Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company with
focus on autoimmune/inflammatory diseases and cancer. Projects in or entering
pivotal phase are laquinimod, an orally administered small molecule with unique
immunomodulatory properties for the treatment of multiple sclerosis, TASQ for
prostate cancer as well as ANYARA for use in cancer targeted therapy, primarily
of renal cell cancer. In addition, laquinimod is in Phase II development for
Crohn's and Lupus. Further projects in clinical development comprise the two
orally administered compounds, 57-57 for SLE & Systemic Sclerosis and RhuDex(TM)
for RA. Please visitwww.activebiotech.com for more information.
Active Biotech is obligated to publish the information contained in this press
release in accordance with the Swedish Securities Market Act. This information
was provided to the media for publication on November 3, 2010 at 2:00 p.m.
Active Biotech AB
PO Box 724, SE-220 07 Lund
Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00
www.activebiotech.com
[HUG#1458531]
Active Biotech's election committee appointed:
http://hugin.info/1002/R/1458531/398027.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Active Biotech via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 03.11.2010 - 14:00 Uhr
Sprache: Deutsch
News-ID 48372
Anzahl Zeichen: 3011
contact information:
Town:
LUND
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 209 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Active Biotech's election committee appointed"
steht unter der journalistisch-redaktionellen Verantwortung von
Active Biotech (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
